Advertisement

Phenotypic Cellular Changes in Multistage Carcinogenesis

  • Peter Bannasch

Abstract

The concept that carcinogenesis is a multistage process comprising initiation, promotion and progression has mainly been inferred from experiments in which certain operational steps were used to induce tumors of the skin, liver or other tissues (Pitot, 1988). However, an unequivocal explanation of initiation, promotion and progression in biological terms has not been reached by this experimental approach. The more recent discovery of characteristic sequential cellular changes during neoplastic development in different organs, especially in the liver, has opened a new approach for the distinction of stages of carcinogenesis which can now be defined by biological rather than operational criteria (Bannasch, 1988). In many tissues, preneoplastic foci composed of phenotypically altered cells emerging weeks and months before benign or malignant tumors appear have been described (Carter, 1984; IARC, 1986). The diagnosis of foci implies that the altered cell populations are perfectly integrated into the normal architecture of the respective tissue and do not show any expansive growth. At the histological level, preneoplasia may be defined as a phenotypically altered cell population which has no obvious neoplastic nature but has a high probability of progressing to a benign or malignant neoplasm (Bannasch, 1986). Frequently, the transition from preneoplastic foci into benign or malignant tumors is associated with additional changes of the cellular phenotype. A precise knowledge of the sequence of phenotypic cellular changes during carcinogenesis is not only a prerequisite for the elucidation of the mechanism of oncogenesis but is also of increasing importance in the assessment of the carcinogenic risk caused by chemicals. In the past few years, preneoplastic lesions have been used with advantage as end points in carcinogenicity testing in a number of laboratories. Sequential cellular changes induced with chemicals in the liver and kidney of rodents will be presented as examples for modulations of the cellular phenotype during carcinogenesis which may help to unravel a general principle underlying the phenotypic diversity of preneoplastic and neoplastic cells, and may improve the evaluation of bioassays for carcinogenicity.

Keywords

Glycogen Storage Disease Preneoplastic Lesion Cell Focus Focal Hepatic Lesion Neoplastic Development 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bannasch, P., 1968, The cytoplasm of hepatocytes during carcinogenesis. Light and electron microscopic investigations of the nitrosomorpholineintoxicated rat liver, Rec. Res. Cancer Res., 19: 1.Google Scholar
  2. Bannasch, P., 1986, Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia and II. Preneoplasia in various non-hepatic tissues, Carcinogenesis, 7:689 and 849.Google Scholar
  3. Bannasch, P., 1988, Phenotypic cellular changes as indicators of stages during neoplastic development, in: “Theories of Carcinogenesis”, O.H. Iversen, ed., Hemisphere Publishing Corporation, Washington.Google Scholar
  4. Bannasch, P., Mayer, D., and Hacker, H.J., 1980, Hepatocellular glycogenosis and hepatocarcinogenesis, Biochim. Biophys. Acta, 605: 217.Google Scholar
  5. Bannasch, P., Hacker, H.J., Klimek, F., and Mayer, D., 1984, Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis, Adv. Enzyme Regul., 22: 97.Google Scholar
  6. Bannasch, P., Benner, U., Enzmann, H., and Hacker, H.J., 1985, Tigroid cell foci and neoplastic nodules in the liver of rats treated with a single dose of aflatoxin B1, Carcinogenesis, 6: 1641.PubMedCrossRefGoogle Scholar
  7. Bannasch, P., Hacker, H.J., Tsuda, H., and Zerban, H., 1986, Aberrant carbohydrate metabolism and metamorphosis during renal carcinogenesis, Adv. Enzyme Regul., 25: 279.Google Scholar
  8. Bannasch, P., Nogueira, E., Zerban, H., Beck, K., and Mayer, D., 1988, Sequential phenotypic conversion of renal epithelial cells during neoplastic development, in: “Chemical Carcinogenesis: Models and Mechanisms, F. Feo, ed., Pergamom Press, London, in press.Google Scholar
  9. Bannasch, P., Nogueira, E., Zerban, H., Beck, K., and Mayer, D., 1988, Sequential phenotypic conversion of renal epithelial cells during neoplastic development, in: “Chemical Carcinogenesis: Models and Mechanisms, F. Feo, ed., Pergamom Press, London, in press.Google Scholar
  10. Buchmann, A., Kuhlmann, W.D., Schwarz, M., Kunz, H.W., Wolf, C.R., Moll, E., Friedberg, T., and Oesch, F., 1985, Regulation and expression of four cytochrome P-450 isoenzymes, NADPH-cytochrome P-450 reductase, the glutathione transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver, Carcinogenesis, 6: 513.PubMedCrossRefGoogle Scholar
  11. Bursch, W., Lauer, B., Timmermann-Trosiener, T., Barthel, G., Schuppler, J., and Schulte-Hermann, R., 1984, Controlled cell death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters, Carcinogenesis, 5: 453.PubMedCrossRefGoogle Scholar
  12. Carter, R.L., 1984, “Precancerous States”, Oxford University Press, London, New York, Toronto.Google Scholar
  13. Colomban, A., Ledda-Colomban, G.M., Rao, P.M., Rajalakshmi, S., and Sarnia, D.S.R., 1984, Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells: A sequential study, Am. J. Pathol., 116: 441.Google Scholar
  14. Emmelot, P., and Scherer, E., 1980, The first relevant cell stage in rat liver carcinogenesis: a quantitative approach, Biochim. Biophys. Acta, 605: 247.Google Scholar
  15. Enzmann, H., and Bannasch, P., 1987a, Morphometric studies of alterations of extrafocal hepatocytes of rat liver treated with N-nitrosomorpholine, Virchows Arch. B Cell Pathol., 53: 218.Google Scholar
  16. Enzmann, H., and Bannasch, P., 1987b, Potential significance of phenotypic heterogeneity of focal lesions at different stages in hepatocarcinogenesis, Carcinogenesis, 8: 1607.PubMedCrossRefGoogle Scholar
  17. Enzmann, H., and Bannasch, P., 1988, Non-persisting early foci of altered hepatocytes induced in rats by N-nitrosomorpholine, J. Cancer Res. Clin. Oncol., 114: 30.Google Scholar
  18. Enzmann, H., Edler, L., and Bannasch, P., 1987, Simple elementary method for the quantification of focal liver lesions induced by carcinogens, Carcinogenesis, 8: 231.PubMedCrossRefGoogle Scholar
  19. Enzmann, H., Dettler, T., Ohlhauser, D., and Bannasch, P., 1988, Elevation of glucose-6-phosphate in early stages of hepatocarcinogenesis induced in rats by N-nitrosomorpholine, Horm. metabol. Res., 20: 128.Google Scholar
  20. Farber, E., and Sarma, D.S.R., 1987, Hepatocarcinogenesis: A dynamic cellular perspective, Lab. Invest., 56: 4.Google Scholar
  21. Friedrich-Freksa, H., Papadopulu, G., and GSssner, W., 1969, Histochemische Untersuchungen der Cancerogenese in der Rattenleber nach zeitlich begrenzter Verabfolgung von Diäthylnitrosamin, Z. Krebsforsch., 72: 240.CrossRefGoogle Scholar
  22. Goldsworthy, T.L., and Pitot, H.C., 1985, The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion with phenobarbital, Carcinogenesis, 6: 1261.PubMedCrossRefGoogle Scholar
  23. Goldsworthy, T.L., Hanigan, H.M., and Pitot, H.C., 1986, Models of hepatocarcinogenesis in the rat - Contrasts and comparisons, CRC Crit. Rev. Toxicol., 17: 61.Google Scholar
  24. IARC, 1986, “Long-term and short-term assays for carcinogens: A critical appraisal”, R. Montesano, H. Bartsch, H. Vainio, J. Wilbourn and H. Yamasaki, eds., IARC Scientific Publications, Lyon.Google Scholar
  25. Klimek, F., Moore, M.A., Schneider, E., and Bannasch, P., 1988, Histochemical and microbiochemical demonstration of reduced pyruvate kinase activity in thioacetamide-induced neoplastic nodules of rat liver, Histochemistry, in press.Google Scholar
  26. Kunz, W., Schaude, G., Schwarz, M., and Tennekes, H., 1982, Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications, in: “Carcinogenesis - A Comprehensive Survey”, E. Hecker, N.E. Fusenig, W. Kunz, F. Marks and M.W. Thielmann, eds., Raven Press, New York.Google Scholar
  27. Limmer, J., Fleig, W.E., Leupold, D., Bittner, R., Ditschuneit, H., and Beger, H.G., 1988, Hepatocellular carcinoma in type I glycogen storage disease, Hepatology, 8: 531.PubMedCrossRefGoogle Scholar
  28. Mayer, D., 1988, Regulation of carbohydrate metabolism in a glycogenstoring liver cell line, in: “Experimental Hepatocarcinogenesis”, M.B. Roberfroid and V. Préat, eds., Plenum Press, New York, London.Google Scholar
  29. Moore, M.A., and Kitagawa, T., 1986, Hepatocarcinogenesis in the rat; the effect of the promoters and carcinogens in vivo and in vitro, Int. Rev. Cytol., 101: 125.Google Scholar
  30. Moore, M.A., Mayer, D., and Bannasch, P., 1982, The dose-dependence and sequential appearance of putative preneoplastic populations induced in the rat liver by stop experiments with N-nitrosomorpholine, Carcinogenesis, 3: 1429.PubMedCrossRefGoogle Scholar
  31. Nogueira, E., 1987, Rat renal carcinogenesis after chronic simultaneous exposure to lead acetate and N-nitrosodiethylamine, Virchows Arch. B Cell Pathol., 53: 365.Google Scholar
  32. Nogueira, E., and Bannasch, P., 1988, Cellular origin of rat renal oncocytoma, Lab. Invest., in press.Google Scholar
  33. Pitot, H.C., 1988, Hepatic neoplasia: Chemical induction, in: “The Liver. Biology and Pathobiology”, J.M. Arias, W.B. Jakoby, H. Popper, D. Schachter and D.A. Shafritz, eds., Raven Press, New York.Google Scholar
  34. Rabes, H.M., 1983, Development and growth of early preneoplastic lesions induced in the liver by chemical carcinogens, J. Cancer Res. Clin. Oncol., 106: 85.Google Scholar
  35. Rabes, A.M., 1988, Cell proliferation and hepatocarcinogenesis, in: “Experimental Hepatocarcinogenesis”, M.B. Roberfroid and V. Préat, eds., Plenum Press, New York, London.Google Scholar
  36. Ruebner, B.H., Michas, C., Katayama, R., and Bannasch, P., 1976, Sequential hepatic histologic and histochemical changes produced by diethylnitrosamine in the Rhesus monkey, J. Natl. Cancer, Inst., 57: 1261.Google Scholar
  37. Scherer, E., 1981, Use of a programmable pocket calculatot for the quantitation of precancerous foci, Carcinogenesis, 2: 805.PubMedCrossRefGoogle Scholar
  38. Scherer, E., 1984, Neoplastic progression in experimental hepatocarcinogenesis, Biochim. Biophys. Acta, 738: 219.Google Scholar
  39. Schröter, C., Parzefall, W., Schröter, H., and Schulte-Hermann, R., 1987, Dose-response studies on the effects of a-, 0-, y-hexachlorocyclohexane on putative preneoplastic foci, monooxygenases and growth in rat liver, Cancer Res., 47: 80.PubMedGoogle Scholar
  40. Seelmann-Eggebert, G., Mayer, D., Mecke, D., and Bannasch, P., 1987, Expression and regulation of glycogen phosphorylase in preneoplastic and neo-plastic hepatic lesions in rats, Virchows Arch. B Cell Pathol., 53: 44.Google Scholar
  41. Tatematsu, M., Aoki, T., Kagawa, M., Mera, Y., and Ito, N., 1988a, Reciprocal relationship between development of glutathione S-transferase positive liver foci and proliferation of surrounding hepatocytes in rats, Carcinogenesis, 9: 221.PubMedCrossRefGoogle Scholar
  42. Tatematsu, M., Mera, Y., Inoue, T., Satoh, K., Sato, K., and Ito, N., 1988b, Stable phenotypic expression of glutathione S-transferase placental type and unstable phenotypic expression of y-glutamyltransferase in rat liver preneoplastic and neoplastic lesions, Carcinogenesis, 9: 215.PubMedCrossRefGoogle Scholar
  43. Tsuda, H., Hacker, H.J., Katayama, H., Masui, T., Ito, N., and Bannasch, P., 1986, Correlative histochemical studies on preneoplastic and neo-plastic lesions in the kidney of rats treated with nitrosamines, Virchows Arch. B. Cell Pathol., 51: 385.Google Scholar
  44. Vesselinovitch, S.D., and Mihailovich, N., 1983, Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse, Cancer Res., 43: 4253.PubMedGoogle Scholar
  45. Vesselinovitch, S.D., Hacker, H.J., and Bannasch, P., 1985, Histochemical characterization of focal hepatic lesions induced by single diethylnitrosamine treatment in infant mice, Cancer Res., 45: 2774.PubMedGoogle Scholar
  46. Weber, E., and Bannasch, P., 1988, Dose-dependence of preneoplastic lesion phenotype in N-nitrosomorpholine-induced hepatocarcinogenesis, Falk-Symposium No. 51, Liver Cell Carcinoma, 43.Google Scholar
  47. Weber, E., Moore, M.A., and Bannasch, P., 1988a, Enzyme histochemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liver after combined treatment with dehydroepiandrosterone and N-nitrosomorpholine, Carcinogenesis, 9: 1049.PubMedCrossRefGoogle Scholar
  48. Weber, E., Moore, M.A., and Bannasch, P., 1988b, Phenotypic modulation of hepatocarcinogenesis and reduction in N-nitrosomorpholine-induced hemangiosarcoma and adrenal lesion development in Sprague-Dawley rats by dehydroepiandrosterone, Carcinogenesis, 9: 1191.PubMedCrossRefGoogle Scholar
  49. Zerban, H., Rabes, H.M., and Bannasch, P., 1985, Kinetics of cell proliferation during hepatocarcinogenesis, Europ. J. Cancer Clin. Oncol., 21: 1424.Google Scholar
  50. Zerban, H., Preussmann, R., and Bannasch, P., 1988a, Dose-time-relationship of the development of preneoplastic liver lesions induced in rats with low doses of N-nitrosodiethanolamine, Carcinogenesis, 9: 607.PubMedCrossRefGoogle Scholar
  51. Zerban, H., Preussmann, R., and Bannasch, P., 1988b, Quantitative morpho-metric comparison between the expression of two different “marker enzymes” in preneoplastic liver lesions induced in rats with low doses of N-nitrosodiethanolamine, Cancer Lett., submitted.Google Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Peter Bannasch
    • 1
  1. 1.Institut für Experimentelle PathologieDeutsches KrebsforschungszentrumHeidelbergFederal Republic of Germany

Personalised recommendations